Prestige Consumer Healthcare (PBH) Return on Invested Capital (2014 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Return on Invested Capital of 0.03% for Q4 2025, down 36.0% year-over-year from 0.04% in Q4 2024, and down 26.28% quarter-over-quarter from 0.04% in Q3 2025.
Prestige Consumer Healthcare (PBH) Return on Invested Capital (2014 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.03% for Q4 2025.
- In Q4 2025, Return on Invested Capital fell 36.0% year-over-year to 0.03%; the TTM figure through Dec 2025 stood at 0.03% (down 36.0% YoY), while the FY2025 annual figure was 0.21%, down 64.0% from the prior year.
- Return on Invested Capital for Q4 2025 stood at 0.03%, down from 0.04% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.39% in Q4 2024, with the low at 0.01% in Q4 2023.
- The 5-year median for Return on Invested Capital is 0.07% (2021), against an average of 0.11%.
- The sharpest annual moves came in 2024 and 2025: Return on Invested Capital soared 40 bps in 2024, then sank 36 bps in 2025.
- Prestige Consumer Healthcare's Return on Invested Capital stood at 0.07% in 2021, then soared by 41 bps to 0.1% in 2022, then slumped by 112 bps to 0.01% in 2023, then soared by 3330 bps to 0.39% in 2024, then tumbled by 93 bps to 0.03% in 2025.
- Business Quant data shows PBH's Return on Invested Capital at 0.03% in Q4 2025, 0.04% in Q3 2025, and 0.06% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03% |
| Sep 30, 2025 | 0.04% |
| Jun 30, 2025 | 0.06% |
| Mar 31, 2025 | 0.14% |
| Dec 31, 2024 | 0.39% |
| Sep 30, 2024 | 0.38% |
| Jun 30, 2024 | 0.27% |
| Mar 31, 2024 | 0.21% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.10% |
| Sep 30, 2022 | 0.09% |
| Jun 30, 2022 | 0.08% |
| Mar 31, 2022 | 0.08% |
| Dec 31, 2021 | 0.07% |
| Sep 30, 2021 | 0.06% |
| Jun 30, 2021 | 0.07% |
| Mar 31, 2021 | 0.07% |